Rate of device-related infections using an antibacterial envelope in patients undergoing cardiac resynchronization therapy reoperations.
Maria Hee Jung Park FrausingJens Cosedis NielsenJens Brock JohansenOle Dan JørgensenChristian GerdesThomas OlsenMads Brix KronborgPublished in: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology (2021)
Use of an antibacterial envelope was associated with a clinically and statistically significant reduction in DRIs in patients undergoing CRT reoperations. Our results were comparable to those recently reported from a large randomized controlled trial, which is suggestive of a proportional effect of the envelope even in very high-risk patients.
Keyphrases
- patients undergoing
- cardiac resynchronization therapy
- randomized controlled trial
- end stage renal disease
- left ventricular
- heart failure
- newly diagnosed
- ejection fraction
- chronic kidney disease
- silver nanoparticles
- study protocol
- peritoneal dialysis
- prognostic factors
- systematic review
- clinical trial
- anti inflammatory
- atrial fibrillation
- patient reported